跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HES-130 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
HES-130
Approved
STANDARD
HES-130
Shandong Qidu Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a2dbcbe1ca8d57d9
Company
Shandong Qidu Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
a2dbcbe1ca8d57d9
Drug Approval Philippines Name
HES-130
Product Name
HES-130
Registration Number
DR-XY49045
Brand Name
HES-130
Generic Name
Hydroxyethyl Starch 130/0.4+ Sodium Chloride
Dosage Form
Solution for Injection. (IV)
Dosage Strength
30 g/ 4.5 g (130/0.4) per 500 mL
Manufacturer
Shandong Qidu Pharmaceutical Co., Ltd.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 June 2024
Expiry Date
16 April 2029
Pharmacologic Category
Blood Substitute and Plasma Protein Fractions
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a2dbcbe1ca8d57d9
Type
Standard
Back to Philippines FDA Approvals